These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9610463)

  • 1. Ovarian estradiol production in vivo. Inhibitory effect of leuprolide acetate.
    Kowalik A; Barmat L; Damario M; Liu HC; Davis O; Rosenwaks Z
    J Reprod Med; 1998 May; 43(5):413-7. PubMed ID: 9610463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
    Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
    Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporation of a GnRH agonist, leuprolide acetate, into regimens with exogenous gonadotropins to produce ovarian stimulation and ovulation in the nonpregnant squirrel monkey.
    Kuehl TJ; Davis TW; Young C; Nunez P; Robinson MR; Huddleston KP; Wincek TJ; Pliego JF; Dukelow WR
    Am J Primatol; 1999 Oct; 49(2):153-64. PubMed ID: 10466574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
    Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
    Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High estradiol levels and high oocyte yield are not detrimental to in vitro fertilization outcome.
    Sharara FI; McClamrock HD
    Fertil Steril; 1999 Sep; 72(3):401-5. PubMed ID: 10519607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
    Kahraman K; Berker B; Atabekoglu CS; Sonmezer M; Cetinkaya E; Aytac R; Satiroglu H
    Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leuprolide acetate reduces both in vivo and in vitro ovarian steroidogenesis in infertile women undergoing assisted reproduction.
    Silva AL; Abreu LG; Rosa-e-Silva AC; Ferriani RA; Silva-de-Sá MF
    Steroids; 2008 Dec; 73(14):1475-84. PubMed ID: 18789958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
    Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?
    Schoolcraft WB; Surrey ES; Minjarez DA; Stevens JM; Gardner DK
    Fertil Steril; 2008 Jan; 89(1):151-6. PubMed ID: 17482177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic value assessment of the early response of blood estradiol, FSH, and LH using leuprolide acetate during ovarian hyperstimulation in assisted reproduction].
    Sondón García Z; Alvarado A; Peraza Briones C; González Sánchez R; Jiménez Perea L
    Ginecol Obstet Mex; 2001 Feb; 69():65-71. PubMed ID: 11339176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of nafarelin acetate versus leuprolide acetate in conjunction with human menopausal gonadotropins for superovulation/intrauterine insemination.
    Schmidt-Sarosi CL; Yerovi LA
    Int J Fertil Menopausal Stud; 1994; 39(1):20-5. PubMed ID: 8167676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT; Ohlinger R
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
    Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
    Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial.
    De Placido G; Alviggi C; Perino A; Strina I; Lisi F; Fasolino A; De Palo R; Ranieri A; Colacurci N; Mollo A;
    Hum Reprod; 2005 Feb; 20(2):390-6. PubMed ID: 15576390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of gonadotropin-releasing hormone agonist/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fertilization.
    Fornaro F; Cobellis L; Mele D; Tassou A; Badolati B; Sorrentino S; De Lucia D; Colacurci N
    Fertil Steril; 2007 Jan; 87(1):39-47. PubMed ID: 17084393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
    Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
    Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does plasma insulin level affect ovarian response to exogenous administration of follicle-stimulating hormone in women without polycystic ovary syndrome?
    La Marca A; Pati M; Giulini S; Levratti P; Caretto S; Volpe A
    Gynecol Endocrinol; 2005 Nov; 21(5):292-4. PubMed ID: 16373249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
    Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
    Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovulation induction with GnRH agonist and human menopausal gonadotropins: response in patients with one versus two ovaries.
    Penzias AS; Gutmann JN; Shamma FN; LaMorte AI; DeCherney AH
    Int J Fertil Menopausal Stud; 1993; 38(5):270-3. PubMed ID: 8298665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum CA-125 and inhibin B levels in the prediction of ovarian response to gonadotropin stimulation in in vitro fertilization cycles.
    Urbancsek J; Hauzman EE; Murber A; Lagarde AR; Rabe T; Papp Z; Strowitzki T
    Gynecol Endocrinol; 2005 Jul; 21(1):38-44. PubMed ID: 16048800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.